Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 10, 2014 - Issue
Submit an article Journal homepage
102
Views
5
CrossRef citations to date
0
Altmetric
Review

Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties

Jingping Zhao1 Mental Health Institute of The Second Xiangya Hospital, Hunan Province Technology Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan, People’s Republic of ChinaCorrespondence[email protected]
,
Jianjun Ou1 Mental Health Institute of The Second Xiangya Hospital, Hunan Province Technology Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan, People’s Republic of China
,
Haibo Xue2 Lilly Suzhou Pharmaceutical Co, Ltd, Jiangsu, People’s Republic of China
,
Li Liu2 Lilly Suzhou Pharmaceutical Co, Ltd, Jiangsu, People’s Republic of China
,
William Montgomery3 Global Health Outcomes, Eli Lilly and Company, Sydney, Australia
&
Tamas Treuer4 Emerging Markets Business Unit (Neuroscience), Eli Lilly and Company, Budapest, Hungary
Pages 355-359 | Published online: 19 Feb 2014

References

  • Van OsJKapurSLancet200937463564519700006
  • World Health OrganizationSchizophrenia Available from: http://www.who.int/mental_health/management/schizophrenia/en/Accessed February 27, 2011
  • PhillipsMZhangJXShiQCPrevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–2005: an epidemiological surveyLancet20093732041205319524780
  • LeuchtSBarnesTRKisslingWEngelRRCorrellCKaneJMRelapse prevention in schizophrenia with new generation antipsychotics: a systematic review and exploratory meta analysis of randomized, controlled trialsAm J Psychiatry20031601209122212832232
  • CorriganPWLibermanRPEngelJDFrom noncompliance to collaboration in the treatment of schizophreniaHosp Community Psychiatry199041120312111979044
  • LacroJPDunnLBDolderCRLeckbandSGJesteDVPrevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literatureJ Clin Psychiatry20026389290912416599
  • ChuePJonesBTaylorCCDicksonRDissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophreniaCan J Psychiatry20024777177412420656
  • HsuWYHuangSSLeeBSChiuNYComparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in TaiwanJ Clin Psychopharmacol20103023023420473056
  • KinonBJHillALLiuHKollack-WalkerSOlanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophreniaInt J Neuropsychopharmacol200369710212890301

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.